T2 Biosystems | SC 13D/A:超过5%持股股东披露文件(修正)-Nathan D. Hukill(69.5%),CR Group L.P.(69.5%)等
T2 Biosystems | 4:持股变动声明-股东 CR Group L.P.
T2 Biosystems | SC 13D/A:超过5%持股股东披露文件(修正)-Nathan D. Hukill(65.4%),CR Group L.P.(65.4%)等
T2 Biosystems | 4:持股变动声明-股东 CR Group L.P.
T2 Biosystems | SC 13D:超过5%持股股东披露文件-Nathan D. Hukill(46.68%),CR Group L.P.(46.68%)等
T2 Biosystems | 4:持股变动声明-股东 CR Group L.P.
T2 Biosystems | SC 13G:超过5%持股股东披露文件-JACOB SAFIER(7.1%),NEW DIMENSIONS TRADING LTD.(7.1%)
T2 Biosystems | SC 13G:超过5%持股股东披露文件-JACOB SAFIER(7.1%),NEW DIMENSIONS TRADING LTD.(7.1%)
T2 Biosystems | 4:持股变动声明-高管 Gibbs Michael Terrence
T2 Biosystems | 4:持股变动声明-高管 Sprague John M
T2 Biosystems | 4:持股变动声明-高管 Sperzel John J III
T2 Biosystems | 4:持股变动声明-高管 Sprague John M
T2 Biosystems | 4:持股变动声明-高管 Sperzel John J III
T2 Biosystems | 4:持股变动声明-高管 Giffin Brett A.
T2 Biosystems | 4:持股变动声明-高管 Gibbs Michael Terrence
T2 Biosystems | 4:持股变动声明
T2 Biosystems | SC 13G/A:超过5%持股股东披露文件(修正)-Lind Global Fund II LP(0.5%),Lind Global Partners II LLC(0.5%)等
T2 Biosystems | 4:持股变动声明-董事 Toft Robin
T2 Biosystems | 4:持股变动声明-首席商务官 Giffin Brett A.
T2 Biosystems | 4/A:持股变动声明(修正)-首席商务官 Giffin Brett A.
暂无数据